Analgesics in Switzerland

Date: September 19, 2016
Pages: 27
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A465186681CEN
Leaflet:

Download PDF Leaflet

Although the Swiss population continued to use analgesics to treat minor ailments resulting from stressful and busy lifestyles, their usage dropped slightly in 2016. The medical establishment, as well as the media, widely publicised that the high usage of analgesics can cause adverse health effects in the long term. In addition, many people believe that when treating minor pain with analgesics on a regular basis, these products will have no effect when they want to treat severe pain.

Euromonitor International's Analgesics in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Analgesics by Category: Value 2011-2016
  Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
  Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
  Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
  Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Bayer (schweiz) AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
  Summary 1 Bayer (Schweiz) AG: Key Facts
Competitive Positioning
  Summary 2 Bayer (Schweiz) AG: Competitive Position 2016
Melisana AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
  Summary 3 Melisana AG: Key Facts
Competitive Positioning
  Summary 4 Melisana AG: Competitive Position 2016
Vifor Pharma AG in Consumer Health (switzerland)
Strategic Direction
Key Facts
  Summary 5 Vifor Pharma AG: Key Facts
Competitive Positioning
  Summary 6 Vifor Pharma AG: Competitive Position 2016
Executive Summary
Low Growth in Consumer Health
Internet Sales Are Affected
Large Pharmaceutical Companies Are Popular
Consumers Favour Chemists/pharmacies
Stagnation Expected in Consumer Health in the Forecast Period
Key Trends and Developments
New Legislation Limits Online Retailing
Retailers Contribute To the Growth in Lifestyle Products
Herbal/traditional Products Lose Consumer Demand
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 9 Life Expectancy at Birth 2011-2016
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2011-2016
  Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
  Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 7 OTC: Switches 2014-2016
Sources
  Summary 8 Research Sources












Skip to top


NRT Smoking Cessation Aids in Switzerland US$ 990.00 Sep, 2016 · 20 pages
OTC Pharmaceuticals in Switzerland US$ 350.00 Sep, 2014 · 39 pages
Adult Mouth Care in Switzerland US$ 990.00 Sep, 2016 · 22 pages
Calming and Sleeping in Switzerland US$ 990.00 Apr, 2015 · 27 pages

Ask Your Question

Analgesics in Switzerland
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: